Back

Oxidative stress biomarkers and myocardial dysfunction in a doxorubicin- and trastuzumab-induced rat model of cardiomyopathy

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging in cardio-oncology Systolic and Diastolic Function EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Dong-Hyuk Cho

Korea University Anam Hospital, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Association of echocardiographic radiomics-based features with cardiotoxicity effect in breast cancer patients from the CARDIOCARE project
Assistant Professor L. Lakkas (Ioannina, GR)
Abstract Slides
Presentation thumbnail
Natural shear wave elastography reveals hidden cardiac dysfunction in adult survivors of childhood cancer during cardiopulmonary stress testing
Doctor A. Youssef (Leuven, BE)
Abstract Slides
Presentation thumbnail
The SGLT-2 inhibitor empagliflozin improves myocardial strain,ejection fraction, reduces pro-inflammatory cytokines and H-FABP/troponin in models of anthracyline-induced cardiotoxicity
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Right ventricular strain as a predictor of trastuzumab-induced chemotherapy-related cardiac dysfunction: a meta-analysis
Doctor I. Scott (Newcastle Upon Tyne, GB)
Abstract Slides

Access the full session

Session thumbnail
Imaging in cardio-oncology

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
LV diastolic function: how to deal with challenges
thumbnail
Congress Presentation
Evaluation of diastolic function and LV filling pressures: limitations of current guidelines 

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources